Owned and operated by a cf veteran 
Independent analytical report
Retatrutide 30 mg — Task 203803
Review the report details, original PDF and Janoshik verification record.
Report summary
- Compound
- Retatrutide
- Strength
- 30 mg
- Reported purity
- 99.446%
- Tested quantity
- 28.35 mg
- Report date
- July 25, 2026
- Janoshik task ID
- #203803
Janoshik analysed this 30 mg Retatrutide sample on 25 July 2026, reporting 28.35 mg of Retatrutide at 99.446 percent purity.
The submission went through the same blind GLP-1 panel as the 10 mg and 20 mg samples tested in the same run, which allows the three presentations to be read side by side under identical methodology. An earlier analysis of this presentation from January 2026 is published beneath it.
This certificate describes the submitted sample identified in the report. It does not establish clinical safety, efficacy, suitability for human or veterinary use, or the specifications of future inventory.